Vitiligo epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 50: Line 50:


===Gender===
===Gender===
* There is no clear difference between the prevalence among gender.
* While the majority of reports state that both sexes are equally affected,<ref>{{Cite journal
* Most reports mention that both sexes are equally affected by this disease,<ref>{{Cite journal
  | author = [[Virendra N. Sehgal]] & [[Govind Srivastava]]
  | author = [[Virendra N. Sehgal]] & [[Govind Srivastava]]
  | title = Vitiligo: compendium of clinico-epidemiological features
  | title = Vitiligo: compendium of clinico-epidemiological features
Line 61: Line 60:
  | month = May-June
  | month = May-June
  | pmid = 17558045
  | pmid = 17558045
}}</ref> other studies report a higher incidence in young women.<ref>{{Cite journal
}}</ref> some studies report a higher incidence in young women.<ref>{{Cite journal
  | author = [[Kyriakos P. Kyriakis]], [[Ioulios Palamaras]], [[Efrosyni Tsele]], [[Charalambos Michailides]] & [[Sofia Terzoudi]]
  | author = [[Kyriakos P. Kyriakis]], [[Ioulios Palamaras]], [[Efrosyni Tsele]], [[Charalambos Michailides]] & [[Sofia Terzoudi]]
  | title = Case detection rates of vitiligo by gender and age
  | title = Case detection rates of vitiligo by gender and age
Line 73: Line 72:
  | pmid = 19261030
  | pmid = 19261030
}}</ref>
}}</ref>
* Female are diagnosed earlier than men.
* Females are diagnosed earlier than men.


===Race===
===Race===

Revision as of 17:15, 25 June 2014

Vitiligo Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vitiligo from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Case Studies

Case #1

Vitiligo epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vitiligo epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vitiligo epidemiology and demographics

CDC on Vitiligo epidemiology and demographics

Vitiligo epidemiology and demographics in the news

Blogs on Vitiligo epidemiology and demographics

Directions to Hospitals Treating Vitiligo

Risk calculators and risk factors for Vitiligo epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Vitiligo is a worldwide spread disease that affects around 1% of the total world population. Both male and female are equally affected and a half of patients are diagnosed under the age of 20.

Epidemiology

Prevalence

  • The prevalence of vitiligo is about 1% of the total worldwide population.
  • This varies among geographical areas and age groups, from 0.1% up to more than 2%.[1]
  • Higher prevalence has been found in countries like India, Romania, Uzbekistan and China.[2]

Age

  • 50% of patients with vitiligo are diagnosed before the age of 20. [3]

Gender

  • While the majority of reports state that both sexes are equally affected,[4] some studies report a higher incidence in young women.[5]
  • Females are diagnosed earlier than men.

Race

  • There is no difference between races, but in dark skin patients it is more noticed and has a higher psychological impact.

References

  1. Christian Kruger & Karin Uta Schallreuter (2012). "A review of the worldwide prevalence of vitiligo in children/adolescents and adults". International journal of dermatology. 51 (10): 1206–1212. doi:10.1111/j.1365-4632.2011.05377.x. PMID 22458952. Unknown parameter |month= ignored (help)
  2. Christian Kruger & Karin Uta Schallreuter (2012). "A review of the worldwide prevalence of vitiligo in children/adolescents and adults". International journal of dermatology. 51 (10): 1206–1212. doi:10.1111/j.1365-4632.2011.05377.x. PMID 22458952. Unknown parameter |month= ignored (help)
  3. Virendra N. Sehgal & Govind Srivastava (2007). "Vitiligo: compendium of clinico-epidemiological features". Indian journal of dermatology, venereology and leprology. 73 (3): 149–156. PMID 17558045. Unknown parameter |month= ignored (help)
  4. Virendra N. Sehgal & Govind Srivastava (2007). "Vitiligo: compendium of clinico-epidemiological features". Indian journal of dermatology, venereology and leprology. 73 (3): 149–156. PMID 17558045. Unknown parameter |month= ignored (help)
  5. Kyriakos P. Kyriakis, Ioulios Palamaras, Efrosyni Tsele, Charalambos Michailides & Sofia Terzoudi (2009). "Case detection rates of vitiligo by gender and age". International journal of dermatology. 48 (3): 328–329. doi:10.1111/j.1365-4632.2009.03770.x. PMID 19261030. Unknown parameter |month= ignored (help)

Template:WH Template:WS